Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients
Bradley S Miller,1 Kevin CJ Yuen2 1Pediatric Endocrinology, University of Minnesota Medical School, Minneapolis, MN, USA; 2Department of Neuroendocrinology and Neurology, Barrow Pituitary Center, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, AZ, USACorresponden...
Main Authors: | Miller BS, Yuen KCJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-06-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/spotlight-on-lonapegsomatropin-once-weekly-injection-and-its-potential-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan
by: Miller BS, et al.
Published: (2024-02-01) -
Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study
by: Roy Gomez, et al.
Published: (2023-10-01) -
Adult growth hormone deficiency – benefits, side effects, and risks of growth hormone replacement
by: Mary Lim Reed, et al.
Published: (2013-06-01) -
The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency
by: Yan Liang, et al.
Published: (2022-08-01) -
Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency
by: Ying-Hua Huang, et al.
Published: (2012-07-01)